Bacterial contamination hypothesis: a new concept in endometriosis

Khaleque Newaz Khan, Fujishita A, Akira Fujishita, Koichi Hiraki, Hiraki K, Kitajima M, Michio Kitajima, Masahiro Nakashima, Nakashima M, Fushiki S, Shinji Fushiki, Kitawaki J, Jo Kitawaki
Reproductive medicine and biology · 2018 · vol. 17(2) , pp. 125–133 · doi:10.1002/rmb2.12083 · PMID:29692669 · PMC5902457 · W2789998895
review OA: gold CC0 ⤵ 112 in-corpus citations
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study investigated the bacterial contamination hypothesis in endometriosis, finding microbes in endometrial samples and observing that GnRH agonist treatment worsened intrauterine microbial colonization and endometritis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text ⓘ

This review article discusses a “bacterial contamination” hypothesis for endometriosis, focusing on how Toll-like receptor 4 (TLR4) signaling in innate immune cells and reproductive tract cells could be activated by bacterial endotoxin (LPS) from Gram-negative bacteria. It summarizes evidence that LPS can stimulate macrophages and endometrial stromal/epithelial cells to produce cytokines/chemokines and growth factors via a TLR4–NF-κB pathway, and describes cellular expression patterns of TLR4 that vary by menstrual cycle phase. The paper reports measurements showing higher endotoxin concentrations in menstrual fluid and specific phase-dependent endotoxin levels in peritoneal fluid in women with endometriosis, alongside bacterial culture findings of increased E. coli contamination in menstrual blood, proposing cyclic retrograde contamination as a source of pelvic LPS. As a caveat, it is a conceptual synthesis of disparate studies rather than a single original experiment, and it emphasizes mechanisms and associations rather than definitive causality. This paper is centrally about endometriosis — it proposes bacterial endotoxin (LPS) and TLR4-mediated inflammatory signaling as key drivers in disease development and persistence.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND: Endometriosis is a multifactorial disease that mainly affects women of reproductive age. The exact pathogenesis of this disease is still debatable. The role of bacterial endotoxin (lipopolysaccharide, LPS) and Toll-like receptor 4 (TLR4) in endometriosis were investigated and the possible source of endotoxin in the pelvic environment was examined. METHODS: The limulus amoebocyte lysate test was used to measure the endotoxin levels in the menstrual fluid and peritoneal fluid and their potential role in the growth of endometriosis was investigated. Menstrual blood and endometrial samples were cultured for the presence of microbes. The effect of gonadotrophin-releasing hormone agonist (GnRHa) treatment on intrauterine microbial colonization (IUMC) and the occurrence of endometritis was investigated. MAIN FINDINGS RESULTS: and the endometrial samples were colonized with other microbes. A cross-talk between inflammation and ovarian steroids or the stress reaction also was observed in the pelvis. Treatment with GnRHa further worsens intrauterine microbial colonization, with the consequent occurrence of endometritis in women with endometriosis. CONCLUSION: For the first time, a new concept called the "bacterial contamination hypothesis" is proposed in endometriosis. This study's findings of IUMC in women with endometriosis could hold new therapeutic potential in addition to the conventional estrogen-suppressing agent.
Full text 31,002 characters · extracted from pmc-nxml · 12 sections · click to expand

Source

The residual accumulation of bacterial endotoxin in the pelvic environment can be explained by two possible mechanisms: (1) the translocation of E. coli or endotoxin from the gut through enterocytes and their entry into the pelvic cavity, as demonstrated in one study, 38 and (2) contamination of the menstrual blood by E. coli after ascending migration from the vagina. The authors confirmed, by the bacterial culture method, that the menstrual blood of women with endometriosis was highly contaminated with E. coli , compared to that in the control women. 11 These findings suggested that the contamination of menstrual blood with E. coli in women with endometriosis could be a constant source of bacterial endotoxin in the PF because of a periodic retrograde menstrual flow and that this cyclic event could initiate the TLR4‐mediated growth of endometriosis.

Conflict

The authors declare no conflict of interest. Human Rights Statement and Informed Consent : Approval from the Institutional Review Board of Nagasaki University, Nagasaki, Japan, was obtained for this study. Animal Studies : This article does not contain any study with animal participants that was performed by any of the authors.

Presence

The authors examined the endotoxin concentration for the first time in the MF and PF of women with or without endometriosis. The limulus amoebocyte lysate test was used to measure the endotoxin levels in the PF that had been collected from women with and without endometriosis. With informed consent and a strict aseptic measure, menstrual blood was collected from a proportion of these women. It was found that the endotoxin (LPS) concentration in the MF was four‐to‐sixfold, and significantly higher, in the women with endometriosis than that in those without endometriosis. 11 Regarding the distributed endotoxin concentration in the PF, based on the phases of the menstrual cycle, a maximum concentration during the menstrual phase and a modest concentration in either the proliferative or the secretory phase of the menstrual cycle was found. 11

Biological

The function of LPS in Mφ, endometrial, and endometriotic cells has been observed. The exposure of peritoneal Mφ to LPS significantly increased the production of a number of macromolecules, such as hepatocyte growth factor (HGF), vascular endothelial cell growth factor (VEGF), interleukin (IL)‐6, IL‐8, and tumor necrosis factor‐alpha (TNF‐α) in a dose‐dependent fashion. 12 , 34 , 35 , 36 , 37 This effect of LPS was abrogated by the pretreatment of cells with neutralizing antibodies for TLR4 and also by a LPS antagonist, polymyxin B. 11 This cellular specificity indicates that Mφ respond to LPS through TLR4. The authors also found that both eutopic and ectopic endometrial stromal cells (ESCs) and endometrial epithelial cells (EECs) were able to significantly proliferate in response to LPS and that this growth‐promoting effect of LPS decreased after treatment with anti‐TLR4 antibody. 4 , 10 , 11 It is presumed that the blocking of TLR4 is effective in order to suppress the inflammatory response in the pelvic environment and cell growth. Another study indicated that the TLR4 system might represent local immunity in the human endometrium, with different modes of TLR4 actions between the ESCs and the EECs. 31 As a secondary inflammatory mediator, different macromolecules (cytokines/chemokines/growth factors) in the pelvic environment are believed to enhance the growth of endometriosis. The authors reported that as an initial inflammatory mediator, bacterial endotoxin (LPS) could be a potential inflammatory mediator of Mφ stimulation and the consequent production of HGF, VEGF, IL‐6, and TNF‐α in the pelvic environment. 11 , 36 This LPS, together with LPS‐induced secondary inflammatory mediators, are possibly involved in the growth of endometriosis in an autocrine or paracrine mechanism. 36 , 37 In addition to TLR4 blocking, the stimulating effect of LPS can be abrogated after treatment with NF‐kB inhibitor. 37 This was confirmed in another experiment using ESCs that had been derived from chocolate cyst linings of the ovary. The authors demonstrated that NF‐kB inhibitor was able to significantly suppress LPS‐stimulated TNF‐α and IL‐8 production by ESCs, as well as ESC proliferation. This indicates that as an initial inflammatory mediator, the functional activity of LPS is regulated by both TLR4 at the receptor level on the cell surface and by NF‐kB at the nucleus. It is presumed that a substantial amount of endotoxin in the menstrual fluid (MF) and PF could be involved in pelvic inflammation and could promote the TLR4/NF‐kB‐mediated growth of endometriosis.

Conclusion

The authors proposed for the first time a new concept called the “bacterial contamination hypothesis” in endometriosis and the involvement of the LPS/TLR4 cascade in the growth regulation of endometriosis. This study's results suggest that a substantial amount of endotoxin in PF related to the reflux of menstrual blood is involved in pelvic inflammation and could promote the TLR4‐mediated growth and progression of endometriosis. A diagrammatic representation of this new concept on endometriosis is shown in Figure  2 . As endometriosis is a multifactorial disease, it should be remembered that a persistent cross‐talk between inflammation and ovarian steroids and the stress reaction occurs in the pelvic environment that can further induce the growth and progression of endometriosis. Although different literature until now claimed that targeting bacterial endotoxin or TLR4 and NF‐kB could be useful as a therapeutic strategy to suppress pelvic inflammation and the growth of endometriosis, their clinical application is questionable. The authors have learned from their continuous study for the last 15 years that, as an inflammatory mediator, LPS could be the initial trigger and bacterial contamination its source in the intrauterine environment that could be the primary cause in the growth regulation of endometriosis, either alone or in combination with ovarian steroids or a tissue stress reaction in the pelvis. The authors' most recent studies further indicated the occurrence of subclinical uterine infection and endometritis in women with endometriosis after GnRHa treatment. These findings could have some epidemiological and biological impact in better understanding the pathogenesis of endometriosis and its related disease burden. The worsening of intrauterine microbial colonization and a higher occurrence of endometritis in GnRHa‐treated women with endometriosis may hint to some future therapeutic potential in their management, as well as the prevention of the recurrence of endometriosis. If prevention is still better than cure, the intravaginal or oral application of some probiotics and/or antibiotics could offer some protection against subclinical vaginal or uterine infection, with a consequent improvement in the quality of life and fertility outcome of women who suffer from this enigmatic disease. Further studies are required to strengthen this study's proposed concept in the management of endometriosis. Diagrammatic presentation of the lipopolysaccharide ( LPS )/Toll‐like receptor ( TLR )4 cascade in the bacterial contamination hypothesis of endometriosis. The constant release of LPS from Escherichia coli ( E. coli) contamination of the menstrual blood causes a higher endotoxin ( LPS ) concentration in the menstrual blood and consequently higher levels of endotoxin in the PF due to the retrograde flow of menstrual blood into the pelvis. Peritoneal macrophages, eutopic and ectopic endometrial epithelial cells, and epithelial stromal cells express TLR 4, a receptor for LPS . The LPS / TLR 4 complex induces pelvic inflammation and promotes the growth and progression of endometriosis via intracellular adaptor molecules and nuclear factor kappa‐light‐chain‐enhancer of activated B cells activation

Association

The common problems of women who suffer from endometriosis are an impairment in the quality of life and producing a state of subfertility or infertility. A number of mechanisms have been proposed to support these adverse effects of endometriosis. 64 , 65 , 66 , 67 , 68 , 69 As endometriosis is a chronic inflammatory disease, a moderate‐to‐severe inflammatory reaction in the pelvic environment of women with endometriosis leads to the formation of tubo‐ovarian adhesion or peri‐tubal adhesion, finally resulting in the narrowing or occlusion of the Fallopian tubes. 66 , 67 , 68 On the contrary, bacterial endotoxin (LPS) that has been derived from Gram‐negative bacteria can directly cause endometrial or tubal damage. Endotoxin has been found to be deleterious to pre‐implantation stage embryos. 70 The presence of endotoxin in in vitro fertilization (IVF) culture media results in a high rate of polyspermy, decreased embryo cleavage rate, and blastocyst formation in human and bovine species. 70 A recent assisted reproductive technology clinical trial demonstrated that the pregnancy rate after IVF–embryo transfer was significantly higher in those women with an endotoxin level of 200 pg/mL. 69 All these accumulated findings indicate that, in addition to an inflammatory reaction, different ligands that are derived from different microbes in the intrauterine environment can induce a variable detrimental effect on the reproductive outcome and that this adverse effect also could occur in women with endometriosis. Endotoxin also possesses the capacity to induce the apoptosis of cells by impairing sperm motility and inducing spermicidal activity. 70 A recent study demonstrated the expression of TLR4 and TLR2 in human and mouse sperm and measured suboptimal concentrations of endotoxin and peptidoglycan in human semen. 70 It was found that the addition of LPS (the ligand of TLR4) and peptidoglycan (the ligand of TLR2) in the absence of leukocytes directly and significantly reduced the motility and increased the apoptotic rate of both human and mouse sperm and suppressed fertilization by sperm both in vivo and in vitro. 70 These findings further strengthened the detrimental effect of bacterial endotoxin on the reproductive outcome. Recently, an elegant effort was made to find the evidence that the endometrial microbiota has an effect on implantation success or failure. The molecular detection of microbiota in the endometrial fluid demonstrated the existence of an endometrial microbiota that is highly stable during the acquisition of endometrial receptivity. 71 When bacterial communities from paired endometrial fluid and vaginal aspirate samples within the same women were analyzed, different bacterial communities were identified between the uterine cavity and the vagina of some participants. A similar study also found that the presence of a range of microbial candidates in a receptive endometrium was associated with significant decreases in implantations, pregnancies, ongoing pregnancies, and live birth rates in infertile women who were undergoing IVF. 71 These findings further added an association between intrauterine microbial colonization and an adverse reproductive outcome. Chronic endometritis (CE) was found to be a frequent finding in the women with recurrent implantation failure (RIF) after IVF. A CE was identified in 30% of patients with RIF and those women with biopsy‐proven CEs had lower implantation rates than those with absent CE. 72 , 73 A subsequent study proposed antibiotic therapy in patients with CE. The implantation rate and ongoing pregnancy rate were significantly increased after the antibiotic treatment of the women with hysteroscopy‐proven CE. 74 Two recent studies further documented that CE that is associated with infection with common bacteria is associated with RIF and emphasized the importance of an antibiotic treatment in improving the reproductive outcome at a subsequent IVF cycle. 74 , 75 Based on these findings, it is presumed that CE secondary to intrauterine microbial colonization could have a potential detrimental effect on the reproductive outcome and could warrant the early diagnosis of CE and necessary therapeutic management of patients who are suffering from repeated implantation or pregnancy failure.

Mechanistic

The authors have proposed two mechanisms that were involved in the E. coli contamination of the menstrual blood: (1) higher prostaglandin E 2 (PGE 2 ) levels in the MF and PF of women with endometriosis was involved in the bacterial growth of E. coli in a bacterial culture system 39 and that this effect of PGE 2 on bacteria might be contributed to by its direct growth‐promoting effect on E. coli or by its indirect immunosuppression effect on peripheral blood lymphocytes 39 and (2) the decreased expression of antimicrobial peptides, such as human β‐defensin (HBD) and/or secretory leukocyte protease inhibitor (SLPI), in the endometrium. Usually, HBD and SLPI are expressed by the epithelial layers of the vagina, ectocervix, endocervix, endometrium, and fallopian tubes. 40 These antimicrobial peptides are normally regulated by cyclic estrogen 40 and their expression pattern might be down‐regulated after estradiol (E2)/progesterone withdrawal during menstruation. The decreased expression of the antimicrobial peptides in the intrauterine or intravaginal luminal epithelium during the menstrual phase could be involved in the bacterial contamination of menstrual blood in women with endometriosis.

Toll‐Like

Until recently, 11 different members have been reported in the family of mammalian TLRs. Among them, TLRs1‐9 are conserved between the human and the mouse. 14 , 15 TLR10 appears to be functional in the human, but non‐functional in the mouse. On the contrary, mouse TLR11 appears to be functional, but non‐functional in the human. 16 Initially, a potential role of TLR4 was established in the recognition of the microbial component. 17 However, subsequent studies revealed important roles of the individual TLRs in recognizing specific microbial components that are derived from pathogens, including bacteria, fungi, protozoa, and viruses. A detailed description of the different TLRs, their respective ligands, and their intracellular mode of action already have been reported. 9 , 18 , 19 Here, we focus on the role of TLR4 in endometriosis. There are two types of ligands, exogenous and endogenous, for TLR4. 20 Bacterial endotoxin or LPS, F protein from the respiratory syncytial virus, chlamydial heat shock protein (Hsp)60, and taxol, a plant‐derived anticancer reagent, all belong to the exogenous ligands of TLR4. The action of taxol mimics the action of LPS in mice but not in humans. 20 The endogenous ligands of TLR4 comprise fibrinogen, fibronectin, heparin sulphate, hyaluronic acid, and Hsps60 and 70. Although a minimal concentration of LPS has the ability to activate TLR4, all the endogenous ligands need very high concentrations to activate TLR4. 20 , 21 , 22 , 23 The detailed signaling pathways of TLR4 in response to LPS are described elsewhere. 24 , 25 It seems that all the TLR signaling pathways are similar and elicit similar biological responses, except TLR3. Lipopolysaccharide is immediately captured by LPS‐binding protein that delivers LPS to TLR4 or CD14 soon after its release in bodily fluids. Lipopolysaccharide is a potent activator of Mφ and other dendritic cells. Different monocyte markers, including CD14, lack a trans‐membrane domain and thus are incapable of transducing signals. 26 Once LPS/TLR4 binds with TLR4, it stimulates a cascade of intracellular adopter molecules and triggers the gene expression of a number of target molecules (cytokines/chemokines/growth factors) by inducing nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐kB) activation. 4 It is commonly understood that the upper genital tract is vulnerable to the spread of microorganisms from the lower genital tract, resulting in the development of infectious diseases, such as endometritis and salpingitis. In fact, an enormous number of Gram‐negative and Gram‐positive microbes is present in the vaginal cavity. All these microbes reside in the vaginal cavity as normal vaginal flora and can cause genitourinary infections on ascending migration. 27 Escherichia coli (E. coli) are the most commonly isolated pathogenic bacteria in the bovine and also in the human vaginal cavity. 28 , 29 It is speculated that the ascending migration of E. coli towards the endometrial cavity is possible and may cause contamination of the endometrium, based on the phases of the menstrual cycle. Nine TLRs already are identified at the protein and messenger (m)RNA level, including TLR4, in the human endometrium. 12 , 30 , 31 As a component of the innate immune system, an increase in the infiltration of Mφ has been found in the normal endometrium and also in the endometrium of women with different reproductive diseases. 32 , 33 A number of recent studies reported the expression of TLR4 mRNA and protein in Mφ, endometrial and endometriotic epithelial cells, and stromal cells. 11 , 12 , 31 The distributing pattern of TLR4 in Mφ, endometrial cells, and endometriotic cells was found to be identical during the proliferative phase. However, this expression pattern appeared to be higher in the secretory phase of the menstrual cycle. 11 , 12 , 13 This was observed equally for women with and without endometriosis.

Cross‐Talk

The effect of estrogen, either alone or in combination with initial or secondary inflammatory mediators, on the growth regulation of endometriosis has been reported. 52 , 53 , 54 , 55 The authors previously demonstrated the Mφ‐mediated production of HGF, VEGF, IL‐6, and TNF‐α in response to ovarian steroids, which was further enhanced after treatment with LPS. 52 , 54 An additive effect was observed between E2 and LPS on the Mφ‐mediated secretion of macromolecules and on the proliferation of eutopic and ectopic endometrial stromal cells, when compared with their single treatment. 53 , 54 , 55 This effect of E2 plus LPS on cell growth was markedly abrogated after pretreatment of the cells with anti‐TLR4 antibody and intracervical insemination, an estrogen antagonist. 53 , 54 These findings suggested that E2 exhibited a pro‐inflammatory response and that an immune–endocrine cross‐talk between estrogen and endotoxin in the pelvic environment could be involved as an additive inflammatory response in the pelvic environment and growth of endometriosis.

Intrauterine

Information regarding the existence of a subclinical vaginal infection or subclinical uterine infection in women with and without endometriosis is limited. Recently, the authors examined the intravaginal pH of women with and without endometriosis, with the concept that although an acidic intravaginal environment protects from infection, a shifting of the vaginal pH towards an alkaline environment increases the risk of microbial colonization. 59 There was found a significant shifting of the intravaginal pH to ≥4.5 in those women with endometriosis, compared to the control women (79.3% vs 58.4%, P  < 0.03, X 2 ‐test). Compared to the untreated women, the use of gonadotrophin‐releasing hormone agonist (GnRHa) therapy also shifted the vaginal pH to ≥4.5 in both the control women ( P  = 0.004, X 2 ‐test)) and in the women with endometriosis ( P  = 0.03, X 2 ‐test). There was not found any difference in the intravaginal pH (<4.5 vs ≥4.5) among the phases of the menstrual cycle in the women with and without endometriosis or between the revised American Society for Reproductive Medicine stages I‐II and III‐IV in the women with endometriosis. The authors investigated the bacteriological evidence of bacterial vaginosis in vaginal smears, based on a modified scoring system of Nugent's criteria. 60 A higher risk was found in increasing the intermediate flora (total score, 4‐6) ( P  = 0.05, X 2 ‐test) and in decreasing the normal vaginal flora (total score, 0‐3) ( P  = 0.007, X 2 ‐test) in the GnRHa‐treated women with endometriosis, compared to the GnRHa‐untreated women. 59 The authors examined the pattern of bacterial growth in the endometrial samples that had been derived from the GnRHa‐treated and ‐untreated women with and without endometriosis, using the bacterial culture method. Among the colony formations of nine different microbial species, according to the treatment status of GnRHa, a significantly increased colony formation was found of Gardnerella and E. coli ( P  < 0.05 for each) in the GnRHa‐treated control women and Gardnerella , Enterococci , and E. coli ( P  < 0.05 for each) was found in the GnRHa‐treated women with endometriosis, compared to the GnRHa‐untreated women. 59 A Kruskal–Wallis test still indicated a higher growth of these microbial species after GnRHa treatment than other microbes. The microbial growth of lactic acid‐producing protective bacteria ( Lactobacillus spp.) was decreased in the endometrial samples that had been derived from the women with endometriosis and after GnRHa treatment. Most recently, the authors confirmed the bacterial culture‐based findings by the molecular method. 61 The authors' finding of IUMC was consequently associated with the occurrence of both acute and chronic endometritis in the women with endometriosis. The occurrence of endometritis was significantly higher in the GnRHa‐treated women than in the GnRHa‐untreated women, with and without endometriosis (control, 68.4% vs 26.5%, P  = 0.003; endometriosis, 85.7% vs 37.2%, P  = 0.001, both by X 2 ‐test). 59 From these recent findings, it is presumed that a worsening of IUMC and a higher occurrence of endometritis could occur in women with endometriosis after GnRHa treatment. These findings of the association between endometriosis and chronic endometriosis were supported by two recently published reports. 62 , 63

Introduction

Endometriosis is a multifactorial disease that mostly affects women of reproductive age and is associated with chronic pelvic pain and infertility. There are some established hypotheses and regulatory factors that support the development or maintenance of this disease. 1 , 2 , 3 , 4 However, it is difficult to uniformly explain the pathogenesis of endometriosis by a single factor. Even after a long 300 years, most of the literature still claims that the pathogenesis and/or pathophysiology of endometriosis is unclear. Studies have shown that the growth and progression of endometriosis continue even in an ovariectomized animal. This indicates that besides ovarian steroid hormones, the growth of endometriosis can be regulated by the innate immune system in the pelvic environment. As a component of the innate immune system, increased infiltration of macrophages (Mφ) has been described in the intact tissue and peritoneal fluid (PF) of women with endometriosis. 5 The understanding of the innate immune system is a result, in large part, from the pioneering studies of Charles Janeway, who demonstrated that innate immunity covers many areas of host defense against pathogenic microbes. 6 During the last decade, investigations of the innate immune system have shown that microbial pathogens are recognized by Toll‐like receptors (TLRs) that, in turn, regulate the activation of both innate and adaptive immunity. 7 Mammalian innate immune cells, such as Mφ and dendritic cells, can be activated by microbial components (non‐self), such as endotoxin or lipopolysaccharide (LPS) from Gram‐negative bacteria. The pattern recognition receptors (PRRs) of the host that recognize pathogen‐associated molecular patterns in the female reproductive tract are expressed on the cells of the innate immune system. Toll‐like receptors are one group of PRRs that are expressed on Mφ, dendritic cells, and as more recently shown, on neutrophils, natural killer cells, and on epithelial cells. 8 , 9 , 10 Originally described over 300 years ago, endometriosis is classically defined by the presence of endometrial glands and stroma in extrauterine locations. 1 Endometriosis is an estrogen‐dependent disease that mostly affects women of reproductive age. Recently, it has been demonstrated that besides hormonal regulation, both secondary (cytokines/growth factors) and initial inflammatory (LPS) mediators are known to be involved in the growth of endometriosis. 2 , 3 , 10 Some of the literature, including the authors', has demonstrated the expression of TLRs in Mφ and other dendritic cells. 11 , 12 , 13 , 14 This review article will discuss: (1) a fundamental concept of the TLR system for easy understanding by the readers, (2) the biological function of the initial inflammatory mediator, bacterial endotoxin or LPS, in the eutopic and ectopic endometria, (3) confirmation of the presence of LPS in the pelvic environment, (4) the source of LPS in menstrual blood, (5) the mechanistic basis of bacterial contamination in the intrauterine environment, (6) cross‐talk between inflammation and the stress reaction in endometriosis, (7) cross‐talk between ovarian steroids and inflammation in endometriosis, (8) the cause–effect of endometriosis on bacterial contamination, (9) the association of intrauterine microbial colonization (IUMC) in women treated and untreated with an estrogen‐suppressing agent, (10) intrauterine microbial colonization after treatment with an estrogen‐suppressing agent, and (11) the possible association of intrauterine bacterial contamination with the reproductive outcome.

Cause–Effect

The most critical question may arise now: “Is this bacterial contamination the effect of endometriosis or the cause of endometriosis?” Based on the authors' serial experiments, the conclusion is that bacterial contamination in menstrual blood could be the effect of endometriosis and, at the same time, also might develop endometriosis. It was demonstrated that LPS regulates the expression of HGF and its receptor, c‐Met, in the PF, ESCs, and EECs. 3 , 11 , 34 , 36 Compared to the control women, a higher concentration of HGF in the PF and MF of women with endometriosis caused the scattering of the EECs and ESCs in a dose‐dependent fashion. Boyden's chamber assay/matrigel in vitro assay indicated that HGF significantly increased the migration and invasion of ESCs. 34 , 36 , 52 These findings suggested that LPS‐induced HGF might be involved in the retrograde passage of cells during menstruation, with consequent cellular invasion once the endometrial cells came into contact with the peritoneal mesothelium. Bacterial endotoxin (LPS) has been reported to regulate a number of cell–cell adhesion molecules (intercellular adhesion molecule 1/vascular cell adhesion molecule 1/fibronectin/laminin) and their receptors (integrin α3 and integrin α6). 56 , 57 , 58 Recently, the authors collected endometrium and its corresponding peritoneum from the same patients during the menstrual phase in order to examine the expression pattern of cell–cell contact molecules. The immunohistochemistry study indicated that two cell–cell adhesion molecules, fibronectin and laminin, were highly expressed in both gland cells and stromal cells. Interestingly, the flat mesothelial cells of the peritoneum that had been derived from these patients displayed a higher expression of integrin α3, a receptor for fibronectin, and integrin α6, a receptor for laminin (Figure  1 ). These findings suggest that LPS‐induced fibronectin and laminin might help in the cellular attachment to the peritoneal mesothelium after binding with their corresponding receptors once degraded functional endometrial cells appear in the pelvis during the period of menstruation. Immunohistochemical expressions of the cell–cell adhesion molecules, fibronectin and laminin, in the eutopic endometria (upper panel) and their corresponding receptors, integrin α3 and integrin α6, in the pelvic peritoneum (lower panel). All these tissue samples were collected from women with endometriosis during the menstrual phase. Fibronectin and laminin were highly expressed in the gland cells and stromal cells of the eutopic endometria. Similarly, integrin α3 and integrin α6 were expressed in the mesothelial cells of the pelvic peritoneum that was derived from the same patient All these findings of HGF and fibronectin and laminin in the endometrial and mesothelial cells could suggest that, after bacterial contamination, as an initial inflammatory mediator, LPS could have an indirect effect on the development and progression of endometriosis.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (77)

Cited by (50)

Source provenance

europepmc
last seen: 2026-08-14T06:11:53.302379+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:19:49.066213+00:00
License: CC0 · commercial use OK